Neuronetics, Inc.
STIM- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001227636
In the last 90 days, Neuronetics, Inc. insiders filed 2 open-market purchases and 0 sales; 86 institutions reported holding it in 13F filings for Q2 2026, worth $48.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Neuronetics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- −7 vs. Q2 2021
- Shares held
- 21.3M
- −2.01M (−8.6%) vs. Q2 2021
- Total value
- $139.9M
- −$233.8M (−62.6%) vs. Q2 2021
- New holders
- 15
- 49 more added
- Sold out
- 22
- 21 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $48.4M |
| Q1 2026 | 99 | $60.4M |
| Q4 2025 | 95 | $58.3M |
| Q3 2025 | 99 | $57.8M |
| Q2 2025 | 90 | $63.1M |
| Q1 2025 | 102 | $63.2M |
| Q4 2024 | 45 | $12.2M |
| Q3 2024 | 48 | $8.05M |
| Q2 2024 | 67 | $31.5M |
| Q1 2024 | 66 | $84.2M |
| Q4 2023 | 66 | $46.2M |
| Q3 2023 | 56 | $23.4M |
| Q2 2023 | 69 | $38.6M |
| Q1 2023 | 74 | $53.6M |
| Q4 2022 | 82 | $120.4M |
| Q3 2022 | 76 | $54.4M |
| Q2 2022 | 77 | $56.4M |
| Q1 2022 | 83 | $59.9M |
| Q4 2021 | 80 | $89.0M |
| Q3 2021 | 97 | $139.9M |
| Q2 2021 | 105 | $373.7M |
| Q1 2021 | 83 | $256.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Neuronetics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Calamos Advisors LLC | 0 | $0 | 0.00% | −363,468−100.0% | Sold out |
| Friess Associates LLC | 0 | $0 | 0.00% | −291,700−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −271,340−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −263,596−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −206,090−100.0% | Sold out |
| Essex Investment Management Co LLC | 0 | $0 | 0.00% | −190,163−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −184,554−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −79,484−100.0% | Sold out |
| Oberweis Asset Management Inc | 0 | $0 | 0.00% | −78,500−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −56,561−100.0% | Sold out |
| David J Yvars Group | 0 | $0 | 0.00% | −32,740−100.0% | Sold out |
| DuPont Capital Management Corp | 0 | $0 | 0.00% | −20,476−100.0% | Sold out |
| Nwam LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −16,366−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,826−100.0% | Sold out |
| Spouting Rock Asset Management, LLC | 0 | $0 | 0.00% | −11,516−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −10,070−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −7,710−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,240−100.0% | Sold out |
| FormulaFolio Investments, LLC | – | – | – | – | Not filed |